The enduring success of copyright’s flagship drug has undeniably transformed the pharmaceutical landscape. However, investing in companies heavily reliant on copycat drugs and the waning patent exclusivity https://sachinncle160023.dgbloggers.com/41427139/the-blue-pill-and-pharma-a-risky-venture